Literature DB >> 35292531

Conceptual Framework for Patient-Reported Outcome Measures in Clinical Trials of Skeletal Muscle Cramping Experienced in Dialysis: A Kidney Health Initiative Workgroup Report.

Michelle M Richardson1,2, Amanda Grandinetti3, Tandrea S Hilliard-Boone4, Kenneth R Wilund5, Rebecca Wingard6, Wendy L St Peter7, Dilani Logan8, Francesca Tentori9, San Keller4, Melissa West10, Eduardo Lacson11,2.   

Abstract

Skeletal muscle cramping is a common and bothersome symptom for patients on maintenance dialysis therapy, regardless of modality, and it has not been prioritized for innovative assessments or treatments. Research to prevent or treat skeletal muscle cramping in patients receiving dialysis is hindered by poorly understood pathophysiology, lack of an accepted definition, and the absence of a standardized measurement method. The Kidney Health Initiative, a public-private partnership between the American Society of Nephrology and US Food and Drug Administration, convened a multidisciplinary workgroup to define a set of patient-reported outcome measures for use in clinical trials to test the effect of new dialysis devices, new KRTs, lifestyle/behavioral modifications, and medications on skeletal muscle cramping. Upon determining that foundational work was necessary, the workgroup undertook a multistep process to elicit concepts central to developing the basis for demonstrating content validity of candidate patient-reported outcome measures for skeletal muscle cramping in patients on dialysis. The workgroup sought to (1) create an accepted, patient-endorsed definition for skeletal muscle cramping that applies to all dialysis modalities, (2) construct a conceptual model for developing and evaluating a skeletal muscle cramping-specific patient-reported outcome measure, and (3) identify potential questions from existing patient-reported outcome measures that could be modified or adapted and subsequently tested in the dialysis population. We report the results of the workgroup efforts, provide our recommendations, and issue a call to action to address the gaps in knowledge and research needs we identified. These action steps are urgently needed to quantify skeletal muscle cramping burden, assess the effect, and measure meaningful changes of new interventions to improve the experience of patients receiving dialysis and suffering from skeletal muscle cramping.
Copyright © 2022 by the American Society of Nephrology.

Entities:  

Keywords:  dialysis; focus group; literature review; muscle cramping; patient-reported outcome measure

Year:  2022        PMID: 35292531      PMCID: PMC9528264          DOI: 10.2215/CJN.11980921

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   10.614


  32 in total

1.  Content validity--establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO good research practices task force report: part 1--eliciting concepts for a new PRO instrument.

Authors:  Donald L Patrick; Laurie B Burke; Chad J Gwaltney; Nancy Kline Leidy; Mona L Martin; Elizabeth Molsen; Lena Ring
Journal:  Value Health       Date:  2011-10-13       Impact factor: 5.725

2.  Rethinking the Cause of Exercise-Associated Muscle Cramping: Moving beyond Dehydration and Electrolyte Losses.

Authors:  Kevin C Miller
Journal:  Curr Sports Med Rep       Date:  2015 Sep-Oct       Impact factor: 1.733

3.  Toward Patient-Centered Innovation: A Conceptual Framework for Patient-Reported Outcome Measures for Transformative Kidney Replacement Devices.

Authors:  Jennifer E Flythe; Tandrea S Hilliard; Kourtney Ikeler; San Keller; Debbie S Gipson; Amanda C Grandinetti; Robert J Nordyke; Ronald D Perrone; Prabir Roy-Chaudhury; Mark Unruh; Melissa West; Fraser Bocell; Frank P Hurst
Journal:  Clin J Am Soc Nephrol       Date:  2020-04-10       Impact factor: 8.237

4.  Effect of Magnesium Oxide Supplementation on Nocturnal Leg Cramps: A Randomized Clinical Trial.

Authors:  Noga Roguin Maor; Mordechai Alperin; Elena Shturman; Hassan Khairaldeen; Moran Friedman; Khaled Karkabi; Uzi Milman
Journal:  JAMA Intern Med       Date:  2017-05-01       Impact factor: 21.873

5.  Stimulating Patient Engagement in Medical Device Development in Kidney Disease: A Report of a Kidney Health Initiative Workshop.

Authors:  Frank P Hurst; Dolph Chianchiano; Linda Upchurch; Benjamin R Fisher; Jennifer E Flythe; Celeste Castillo Lee; Terri Hill; Carolyn Y Neuland
Journal:  Am J Kidney Dis       Date:  2017-04-27       Impact factor: 8.860

6.  Prevalence, correlates and impact of pain and cramps in anti-MAG neuropathy: a multicentre European study.

Authors:  Y A Rajabally; E Delmont; F L Hiew; A-C Aubé-Nathier; A-M Grapperon; J Cassereau; S Attarian
Journal:  Eur J Neurol       Date:  2017-10-19       Impact factor: 6.089

7.  Natural history of muscle cramps in amyotrophic lateral sclerosis.

Authors:  James B Caress; Stephanie L Ciarlone; Elizabeth A Sullivan; Leah P Griffin; Michael S Cartwright
Journal:  Muscle Nerve       Date:  2015-09-28       Impact factor: 3.217

8.  Prevalence and morbidity associated with muscle cramps in patients with cirrhosis.

Authors:  Hemant Chatrath; Suthat Liangpunsakul; Marwan Ghabril; Julie Otte; Naga Chalasani; Raj Vuppalanchi
Journal:  Am J Med       Date:  2012-07-24       Impact factor: 4.965

9.  Evaluation of physical symptoms in patients on peritoneal dialysis.

Authors:  Ana Elizabeth Figueiredo; Cate Goodlad; Michelle Clemenger; San San Haddoub; Jacqueline McGrory; Kim Pryde; Emma Tonkins; Nora Hisole; Edwina Anne Brown
Journal:  Int J Nephrol       Date:  2012-09-25

10.  Pilot study of orphenadrine as a novel treatment for muscle cramps in patients with liver cirrhosis.

Authors:  Sherief Abd-Elsalam; Ferial El-Kalla; Lobna A Ali; Samah Mosaad; Walaa Alkhalawany; Berihan Elemary; Rehab Badawi; Asmaa Elzeftawy; Amr Hanafy; Asem Elfert
Journal:  United European Gastroenterol J       Date:  2017-09-06       Impact factor: 4.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.